4613-08-5

Basic information

• Product Name: Acetamide, N-(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-(phenylmethyl)-
• CAS NO: 4613-08-5
• Molecular Formula: C19H14ClNO3
• Molecular Weight: 339.778
• Mol File: 4613-08-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 116-117 °C
• Boiling Point: 501.6±50.0 °C(Predicted)
• Density: 1.37±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Acetamide, N-(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-(phenylmethyl)-(4613-08-5)
• EPA Substance Registry System: Acetamide, N-(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-(phenylmethyl)-(4613-08-5)

Safety Data

• Hazardous Substances Data: 4613-08-5(Hazardous Substances Data)

Upstream product

• 117-80-6 2,3-Dichloro-1,4-naphthoquinone 
• 100-46-9 benzylamine 
• 4497-69-2 2-chloro-3-(benzylamino)-naphthalene-1,4-dione 
• 108-24-7 acetic anhydride 

Relevant articles and documents

A simple synthesis of 3,4-dihydrobenzo[f]quinoxalin-6(2H)-one derivatives substituted in the ring B

[Figure not available: see fulltext.] We followed a simple, inexpensive, and efficient route to synthesize a series of 3,4-dihydrobenzo[f]quinoxalin-6(2H)-one derivatives substituted in the ring B, with the expectation that this scaffold might exhibit antineoplastic activity. 5-Chlorobenzo[f]quinoxalin-6-ylacetate and 4-benzylbenzo[f]quinoxalin-6(4H)-one were obtained for the first time.

Antiproliferative, DNA intercalation and redox cycling activities of dioxonaphtho[2,3-d]imidazolium analogs of YM155: A structure-activity relationship study

The anticancer agent YM155 is widely investigated as a specific survivin suppressant. More recently, YM155 was found to induce DNA damage and this has raised doubts as to whether survivin is its primary target. In an effort to assess the contribution of DNA damage to the anticancer activity of YM155, several analogs were prepared and evaluated for antiproliferative activity on malignant cells, participation in DNA intercalation and free radical generation by redox cycling. The intact positively charged scaffold was found to be essential for antiproliferative activity and intercalation but was less critical for redox cycling where the minimal requirement was a pared down bicyclic quinone. Side chain requirements at the N1 and N3 positions of the scaffold were more alike for redox cycling and intercalation than antiproliferative activity, underscoring yet again, the limited structural overlaps for these activities. Furthermore, antiproliferative activities were poorly correlated to DNA intercalation and redox cycling. Potent antiproliferative activity (IC50 9-23 nM), exceeding that of YM155, was found for a minimally substituted methyl analog AB7. Like YM155 and other dioxonaphthoimidazoliums, AB7 was a modest DNA intercalator but with weak redox cycling activity. Thus, the capacity of this scaffold to inflict direct DNA damage leading to cell death may not be significant and YM155 should not be routinely classified as a DNA damaging agent.